News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 09, 2016, 17:40 ET Valeant To Participate In FDA Advisory Committee Meeting On July 19

Committee to Review Valeant's BLA 761032 Brodalumab Subcutaneous Injection For Treatment of Adult Patients with Moderate to Severe Plaque Psoriasis...


Jun 07, 2016, 17:00 ET Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...


Jun 07, 2016, 06:00 ET Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results

- Total Revenues of $2.4 billion, an increase of  9% versus the first quarter of 2015 (restated) - GAAP EPS  ($1.08);...


Jun 03, 2016, 07:00 ET Valeant Pharmaceuticals Receives Additional Notice Of Default Under Indentures Due To Delayed Form 10-Q Filing

Notice Does Not Accelerate Any of Valeant's Indebtedness Company Continues to Expect to File Form 10-Q on or Before June 10, 2016 Valeant...


Jun 01, 2016, 07:00 ET Valeant Pharmaceuticals To Present Six Abstracts At 2016 ASCO Annual Meeting

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced the acceptance of five...


May 31, 2016, 18:00 ET Valeant Pharmaceuticals To Hold Conference Call On June 7, 2016

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it plans to host a...


May 26, 2016, 07:00 ET Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") today announced that Sam Eldessouky has been named Senior Vice...


May 23, 2016, 07:00 ET Bausch + Lomb Wins Walmart "Supplier of the Year" Award

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Walmart, one of Valeant's largest customers, has...


May 19, 2016, 18:00 ET Valeant Pharmaceuticals Receives Notice Of Default From Bondholders

Notice Does Not Accelerate Any of Valeant's Indebtedness Company Has Until July 18, 2016 to Cure Default By Filing Form 10-Q Company Continues to...


May 16, 2016, 19:00 ET Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters

Company Expects to File its 10-Q on or before June 10, 2016, as Previously Disclosed  Valeant Pharmaceuticals...


May 16, 2016, 08:00 ET Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that, pursuant to a...


May 09, 2016, 08:00 ET Valeant Pharmaceuticals Announces Expected Timing Of Form 10-Q Filing And Reiterates 2016 First Quarter Guidance

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it expects to file its...


May 05, 2016, 17:00 ET Valeant Pharmaceuticals Announces Patient Access And Pricing Committee To Oversee Pricing Of Drugs

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the formation of a new Patient...


May 05, 2016, 08:00 ET Valeant Pharmaceuticals Announces Collaboration Between Bausch + Lomb And IBM

Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company,...


May 03, 2016, 07:00 ET Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Joseph C. Papa has assumed the role of Chairman and...


Apr 29, 2016, 09:31 ET Valeant Announces Nominees For Election To Board Of Directors

 Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX) (TSX: VRX) today announced the nominees for election to...


Apr 29, 2016, 07:28 ET Valeant Pharmaceuticals Files Annual Report On Form 10-K For Year Ended December 31, 2015

 Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX) (TSX: VRX) today announced that it has filed with the...


Apr 25, 2016, 08:37 ET Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals

Brings More Than Three Decades of Leadership and Operations Experience in Healthcare Valeant Pharmaceuticals International,...


Apr 22, 2016, 17:30 ET Valeant Pharmaceuticals Receives Additional Notices Of Default Under Indentures Due To Delayed 10-K Filing

Notices Do Not Accelerate Any of the Company's Indebtedness The Company is on Schedule to File its 10-K on or before April 29, 2016, as Previously...


Apr 13, 2016, 18:00 ET Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters

Company is on Schedule to File its 10-K on or before April 29, 2016, as Previously Disclosed Valeant Pharmaceuticals International, Inc....